Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
Top Cited Papers
- 1 December 2015
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 149 (7), 1804-1812.e4
- https://doi.org/10.1053/j.gastro.2015.07.061
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic AcidGastroenterology, 2013
- External validation of a Cox prognostic model: principles and methodsBMC Medical Research Methodology, 2013
- Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosisLiver International, 2011
- L1 Penalized Estimation in the Cox Proportional Hazards ModelBiometrical Journal, 2010
- A model to predict survival in patients with end-stage liver diseaseHepatology, 2001
- The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosisHepatology, 2000
- Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?Hepatology, 1999
- Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosisHepatology, 1999
- The Prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary CirrhosisThe New England Journal of Medicine, 1983
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973